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SURGICALTECHNIQUESHVAD continuous flow assist device for ischemic ventricular
septal ruptureAlexander M. Bernhardt, MD, Hermann Reichenspurner, MD, PhD, and Tobias Deuse, MD,
Hamburg, GermanyA ventricular septal defect (VSD) can occur as a severe
complication of extended myocardial infarction (post–
MI-VSD) and has been associated with high mortality.1
According to the Global Registry of Acute Coronary
Events database, post–MI-VSD complicates 0.26% of
acute MIs. In approximately 60% of cases, post–MI-
VSDs will be located in the anteroapical septum as the
result of an occlusion of the left anterior descending ar-
tery. In 40% of patients, the rupture will occur in the pos-
terior septum after occlusion of a dominant right coronaryFIGURE 1. Patient with left anterior descending artery occlusion and post–my
acute MI caused by proximal occlusion of the left anterior descending (arrow). B
the patient went into cardiogenic shock. RV, Right ventricle; LV, left ventricle. C
VSD shunt. D, The patient underwent VSD closure with a modified Dor plasty, c
the HVAD in the typical apical position.
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recommended for post–MI-VSDs, despite the high opera-
tive risk. Post–MI-VSD has been a classic indication for
the implantation of a total artificial heart (TAH) in patients
with extended MI requiring mechanical circulatory sup-
port. However, because TAHs have been associated with
a markedly reduced quality of life and are limited to
bridge-to-transplant patients, modern mechanical circula-
tory support therapy must rely on continuous flow pumps.
We present our surgical strategy for post–MI-VSDs using
the HeartWare HVAD (HeartWare Inc, Framingham,
Mass).
Three male patients (age 46, 47, and 67 years) were
admitted to our institution in cardiogenic shock with
post–MI-VSD. All 3 patients were in Interagency Registry
for Mechanically Assisted Circulatory Support levels 1 or 2
on arrival. Two patients had an occluded left anterior de-
scending artery with subsequent left ventricular (LV) fail-
ure, and the other patient had an occluded right coronary
artery with leading right ventricular (RV) failure. Hemody-
namically relevant VSDs in the anterior or posteriorocardial infarction (MI) ventral septal defect (VSD). A, This patient had an
, An anterior, midseptumVSDwas revealed by left ventriculography when
, A transesophageal echocardiogram showed a hemodynamically relevant
arrying the HVAD sewing ring. E, Postoperative chest radiograph showing
gery c June 2014
FIGURE 2. A patient with right coronary artery occlusion and post–myocardial infarction (MI) ventral septal defect (VSD). A, This patient experienced an
acute MI due to occlusion of the proximal right coronary artery (arrow), which could not be revascularized. He developed a posterior, midseptum VSD,
documented by (B) left ventriculography and (C) transthoracic echocardiography. RV, Right ventricle; LV, left ventricle. He underwent surgical VSD patch
closure and required right ventricular assistance for cardiopulmonary bypass weaning. D, The HVAD was implanted in a right atrium-to-pulmonary artery
configuration. E, The discharge chest radiograph showed the intrapericardial HVAD with the inflow pointing toward the tricuspid valve.
Surgical Techniquesseptum were documented using echocardiography, and all
patients underwent emergency surgery by a single surgeon
(T.D.).
Our surgical strategy was as follows. After a median ster-
notomy and aortic and bicaval cannulation, the heart is ar-
rested using antegrade and retrograde blood cardioplegia.
A 6- to 8-cm left ventriculotomy is performed at the LV
apex, irrespective of the suspected location of the VSD,
and the VSD is evaluated. The defect is closed using a Vas-
cutek patch (Vascutek Terumo, Scotland, UK), secured
within vital myocardium using interrupted pledgeted su-
tures. In patients with left-sided MI, the patch will be
used to close the VSD and remodel the apex. With this
modified Dor plasty, the LV cavity can be reduced in size
(Figure 1). The HVAD sewing ring is attached to the patch
and the HVAD pump inserted. The outflow graft is then con-
nected to the ascending aorta.
In patients with RV infarction, the Vascutek patch is
only used to close the VSD. The LV apex is closed using
horizontal mattress sutures, taking care to limit the trauma
to the left ventricle, and no size reduction or Dor plasty is
performed. The HVAD is inserted into the right atrium
(Figure 2). Although HVAD implantation into the dia-
phragmatic right ventricle has been previously described,2
it can be challenging to place the inflow into a regular size
right ventricle without generating suction events. The
outflow graft is then anastomosed to the main pulmonary
artery.The Journal of Thoracic and CarIn LV assist device (LVAD) patients, the pump speed
should be set cautiously during cardiopulmonary bypass
weaning and the RV function should be closely monitored.
We have not experienced any RV failure in our 2 patients.
Cardiopulmonary bypass weaning is even simpler in RV
assist device (RVAD) patients, because we have never
seen LV failure caused by excessive RVAD flow.
Both LVAD patients recovered well and were discharged.
One patient accidentally died 12 weeks later of fatal device
mishandling. At the last follow-up point, the other patient
was still on the device and in good clinical condition. The
patient with RVAD support was listed for heart transplanta-
tion and successfully underwent transplantation 6 months
later. Because it is still an off-label use, an HVAD RVAD
will not usually be reimbursed by health insurance com-
panies in Germany and needs to be negotiated on an individ-
ual basis.
Post–MI-VSD usually develops within a few days after
MI. In-hospital mortality has been 67% to 82% at 2 months
in these patients with medical therapy only.1 The reported
mortality after surgical repair has varied and has been
approximately 45%. Because of necrotic myocardium
and friable tissue, the risk of persistence or recurrence of
VSD has been approximately 35%.3
According to the current consensus statement from the
International Society for Heart and Lung Transplantation,
an LVAD alone in the setting of an unrepairable post–MI-
VSD is not recommended, and, if possible, permanentdiovascular Surgery c Volume 147, Number 6 1983
Surgical TechniquesLVAD placement should be delayed in the setting of an
acute infarct involving the LV apex.4 In the case of post–
MI-VSD with extensive infarction and a high risk of biven-
tricular failure, a TAH should be implanted.
In an experienced mechanical circulatory support pro-
gram, a 30-day survival rate of 74% can be achieved af-
ter TAH placement in patients with acute biventricular
failure.5 However, the long-term results and quality of
life will be severely impaired by hemolysis, infections,
stroke, noise, and a bulky driver. Our presented technique
might supersede the need for TAH placement in patients
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J Thorac Cardiovasc Surg. 2013;145:e25-6.Bilateral pulmonary artery banding with ligation clips: A novel
technique resistant to residual stenosisYukihiro Kaneko, PhD, Ikuya Achiwa, MD, Hiroyuki Morishita, MD, and Miyuki Shibata, MD, Tokyo,
JapanBilateral pulmonary artery (PA) banding (BPAB) is a
less invasive alternative to the Norwood procedure for
hypoplastic left heart syndrome (HLHS) and related
defects. Conventional BPAB, that is, bilateral PA narrowing
achieved with expanded polytetrafluoroethylene tape, has
its drawbacks, including high risks of residual PA stenosis
after debanding and difficulty in attaining laterally balanced
degree of banding.1,2 Conventional BPAB, which produces
circular narrowing, inevitably reduces PA perimeter
significantly. If PA narrowing could be attained with no or
minimal reduction in its perimeter, the risk of residual PA
stenosis might be reduced.
We have devised a novel BPAB technique whereby
ligation clips are halfway closed into a rhombic shape to
narrow bilateral PAs. Four ligation clip applicators with
small stoppers within the jaws (Hemi Closure; Midorija
Sugiura, Tokyo, Japan) were manufactured to transform a
ligation clip (Horizon clip ML; Teleflex Medical Inc,Research Triangle Park, NC) into a rhombic shape. Each
applicator had a different length of stopper to transform
the clip into a rhombic shape with an internal diagonal of
either 1.0, 1.2, 1.4, or 1.6 mm (Figure 1).
At surgery, bilateral PAs were exposed through a me-
dian sternotomy and encircled with heavy threads. By
gently pulling the threads, ligation clips were applied
around both PAs. When the degree of banding was
deemed inappropriate by oximetry or ultrasound, the
clip was taken out with a clip remover (Hemoclip
remover; Teleflex Medical) and replaced with a different
sized clip.2
The novel BPAB technique was used in 8 neonates with
HLHS and 7 high-risk neonates with congenital heart
defects other than HLHS. Age at operation ranged from
1 to 15 days (median, 3 days). For more precise adjust-
ment of banding, a clip applicator sized 1.3 mm wasFIGURE 1. A clip applicator with a stopper within the jaw (white arrow)
transforms the ligation clip into a rhombus with a shorter internal diagonal
of 1.4 mm (indicated by white line).
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